True. But we need to see expense details; if they're screaming up at the same rate as customer growth, ARR growth is meaningless .
And from next year, customer retention and penetration figures become increasingly important - what proportion of ARR (and ARR growth) is from existing versus new customers, and are they increasing the breadth of product range, plus license volumes deployed products, at existing sites. If those look rosy, well, it promises a bright future especially if they can increase their product portfolio.
- Forums
- ASX - By Stock
- Ann: ARR reaches $18.6 million, up 272% YoY
True. But we need to see expense details; if they're screaming...
Featured News
Add LVT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online